Pertuzumab News

8 Sept 202610:15 pm

finance8 Sept 2026 · 10:15 pm10:15 pm

Active Pine to Divest Up to 1% Biocon Equity Worth Rs 638 Crore via Block Deal

Active Pine is expected to divest up to 1% equity in Biocon, valued at Rs 638 crore, through a block deal, coinciding with Biocon's 10-year partnership in Brazi

8 Sept 202611:33 am

Healthcare8 Sept 2026 · 11:33 am11:33 am

Create visual

Biocon Secures 10-Year Supply Deal for Pertuzumab Breast Cancer Drug in Brazil

Biocon has secured a ten-year contract in Brazil for the distribution of its breast cancer drug Pertuzumab, partnering with Bahiafarma and Bionovis to supply th

Pertuzumab News

#Pertuzumab

Active Pine to Divest Up to 1% Biocon Equity Worth Rs 638 Crore via Block Deal

Biocon Secures 10-Year Supply Deal for Pertuzumab Breast Cancer Drug in Brazil

Discover Faster

Stay Organized

Create Effortlessly

Drive Greater Impact

Newsroom FAQs